Investigator Initiated Clinical Trial of Valganciclovir, An Antiviral Drug for Symptomatic Congenital Cytomegalovirus Disease, Started at Nihon University Itabashi Hospital | Zendy

AI Assistant Blog Pricing

Investigator Initiated Clinical Trial of Valganciclovir, An Antiviral Drug for Symptomatic Congenital Cytomegalovirus Disease, Started at Nihon University Itabashi Hospital

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.